Key result
Urgent OHT in refractory GCM yields functional class I status without recurrence at 1 year.
Why the study?
Giant cell myocarditis in patients with multiple autoimmune disorders and severe heart failure is a rare and life-threatening condition requiring detailed clinical characterization.
Case Report (n=1)
Urgent orthotopic heart transplantation can be a successful, life-saving treatment for refractory giant cell myocarditis, with no recurrence observed at 1 year despite the presence of multiple autoimmune disorders.
Answers are grounded in this paper and cite their sources.
May prompt autoimmune workup in refractory cardiogenic shock; leaves open whether immunosuppression improves outcomes.
A case of circulatory collapse due to severe heart failure is reported in a 52-year old male with autoimmune disorders in the form of type-1 diabetes, Graves' disease and total alopecia.Upon admission, the patient had severe heart failure with a cardiac index of 0.9 l/min/m(2), a mixed venous saturation of 29% and left ventricular ejection fraction of 5%. The condition was refractory to treatment with inotropic agents and required mechanical cardiopulmonary support. Endomyocardial biopsies revealed extensive giant cell myocarditis (GCM). Immunosuppressant treatment did not alter the condition and urgent orthotopic heart transplantation was performed.Histopathological examination of the explanted heart confirmed the diagnosis and showed widespread vascular deposition of complement C4d suggesting a pathogenic role for the innate immune system in GCM.At 1-year follow-up the patient was in New York Heart Association (NYHA) class I, had episodes of sustained ventricular tachycardia but showed no evidence of GCM recurrence in endomyocardial biopsies.
No takes yet. Share an insight, caveat, or question.
Rasmussen et al. (2009) conducted a case report in Giant cell myocarditis and severe heart failure (n=1). Orthotopic heart transplantation was evaluated on Clinical status at 1-year follow-up. Urgent orthotopic heart transplantation in a 52-year-old male with refractory giant cell myocarditis resulted in functional class I status at 1-year follow-up with no evidence of GCM recurrence.
Synapse has enriched 10 related papers. Consider them for comparative context: